These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 10579681)

  • 1. Validation of a pharmacokinetic model of colon-specific drug delivery and the therapeutic effects of chitosan capsules containing 5-aminosalicylic acid on 2,4,6-trinitrobenzenesulphonic acid-induced colitis in rats.
    Tozaki H; Fujita T; Odoriba T; Terabe A; Okabe S; Muranishi S; Yamamoto A
    J Pharm Pharmacol; 1999 Oct; 51(10):1107-12. PubMed ID: 10579681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chitosan capsules for colon-specific drug delivery: enhanced localization of 5-aminosalicylic acid in the large intestine accelerates healing of TNBS-induced colitis in rats.
    Tozaki H; Odoriba T; Okada N; Fujita T; Terabe A; Suzuki T; Okabe S; Muranishi S; Yamamoto A
    J Control Release; 2002 Jul; 82(1):51-61. PubMed ID: 12106976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-Succinyl-chitosan systems for 5-aminosalicylic acid colon delivery: in vivo study with TNBS-induced colitis model in rats.
    Mura C; Nácher A; Merino V; Merino-Sanjuan M; Carda C; Ruiz A; Manconi M; Loy G; Fadda AM; Diez-Sales O
    Int J Pharm; 2011 Sep; 416(1):145-54. PubMed ID: 21723929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of 5-aminosalicyltaurine as a colon-specific prodrug of 5-aminosalicylic acid for treatment of experimental colitis.
    Jung Y; Kim HH; Kim H; Kong H; Choi B; Yang Y; Kim Y
    Eur J Pharm Sci; 2006 May; 28(1-2):26-33. PubMed ID: 16455235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo efficacy of microbiota-sensitive coatings for colon targeting: a promising tool for IBD therapy.
    Karrout Y; Dubuquoy L; Piveteau C; Siepmann F; Moussa E; Wils D; Beghyn T; Neut C; Flament MP; Guerin-Deremaux L; Dubreuil L; Deprez B; Desreumaux P; Siepmann J
    J Control Release; 2015 Jan; 197():121-30. PubMed ID: 25445696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colon-specific delivery of R68070, a new thromboxane synthase inhibitor, using chitosan capsules: therapeutic effects against 2,4,6-trinitrobenzene sulfonic acid-induced ulcerative colitis in rats.
    Tozaki H; Fujita T; Odoriba T; Terabe A; Suzuki T; Tanaka C; Okabe S; Muranishi S; Yamamoto A
    Life Sci; 1999; 64(13):1155-62. PubMed ID: 10210278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vivo Evaluation of 5-ASA Colon-Specific Tablets Using Experimental-Induced Colitis Rat Animal Model.
    Sawarkar SP; Deshpande SG; Bajaj AN; Nikam VS
    AAPS PharmSciTech; 2015 Dec; 16(6):1445-54. PubMed ID: 26017284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetylsalicylic acid-tris-hydroxymethyl-aminomethane reduces colon mucosal damage without causing gastric side effects in a rat model of colitis.
    Varga G; Ugocsai M; Hartmann P; Lajkó N; Molnár R; Szűcs S; Jász DK; Érces D; Ghyczy M; Tóth G; Boros M
    Inflammopharmacology; 2018 Feb; 26(1):261-271. PubMed ID: 28451776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colon-specific delivery of 5-aminosalicylic acid from chitosan-Ca-alginate microparticles.
    Mladenovska K; Raicki RS; Janevik EI; Ristoski T; Pavlova MJ; Kavrakovski Z; Dodov MG; Goracinova K
    Int J Pharm; 2007 Sep; 342(1-2):124-36. PubMed ID: 17590293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dextran-5-(4-ethoxycarbonylphenylazo)salicylic acid ester, a polymeric colon-specific prodrug releasing 5-aminosalicylic acid and benzocaine, ameliorates TNBS-induced rat colitis.
    Nam J; Kim W; Lee S; Jeong S; Yoo JW; Kim MS; Jung Y
    J Drug Target; 2016; 24(5):468-74. PubMed ID: 26377354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A colon-specific prodrug of metoclopramide ameliorates colitis in an experimental rat model.
    Yang Y; Kim W; Kim D; Jeong S; Yoo JW; Jung Y
    Drug Des Devel Ther; 2019; 13():231-242. PubMed ID: 30643389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xylan from Pineapple Stem Waste: a Potential Biopolymer for Colonic Targeting of Anti-inflammatory Agent Mesalamine.
    Anindya AL; Oktaviani RD; Praevina BR; Damayanti S; Kurniati NF; Riani C; Rachmawati H
    AAPS PharmSciTech; 2019 Feb; 20(3):112. PubMed ID: 30761441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioadhesive pellets increase local 5-aminosalicylic acid concentration in experimental colitis.
    Bautzová T; Rabišková M; Béduneau A; Pellequer Y; Lamprecht A
    Eur J Pharm Biopharm; 2012 Jun; 81(2):379-85. PubMed ID: 22386911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-delivery of zinc and 5-aminosalicylic acid from alginate/N-succinyl-chitosan blend microspheres for synergistic therapy of colitis.
    Duan H; Lü S; Qin H; Gao C; Bai X; Wei Y; Wu X; Liu M; Zhang X; Liu Z
    Int J Pharm; 2017 Jan; 516(1-2):214-224. PubMed ID: 27851980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of topical versus oral 5-aminosalicylate for treatment of 2,4,6-trinitrobenzene sulfonic acid-induced ulcerative colitis in rats.
    Li J; Chen C; Cao XN; Wang GH; Hu JB; Wang J
    J Huazhong Univ Sci Technolog Med Sci; 2014 Feb; 34(1):59-65. PubMed ID: 24496680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and in vitro evaluation of chitosan matrices for colonic controlled drug delivery.
    Zambito Y; Di Colo G
    J Pharm Pharm Sci; 2003; 6(2):274-81. PubMed ID: 12935439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ulcerative colitis--colon delivery of 5-aminosalicylic acid].
    Muraoka M; Kimura G; Zhaopeng H; Takada K
    Nihon Rinsho; 1998 Mar; 56(3):788-94. PubMed ID: 9549374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and preclinical development of a novel prodrug conjugate of mesalamine with eicosapentaenoic acid and caprylic acid for the treatment of inflammatory bowel diseases.
    Kandula M; Sunil Kumar KB; Palanichamy S; Rampal A
    Int Immunopharmacol; 2016 Nov; 40():443-451. PubMed ID: 27716592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and characterization of colon specific drug delivery system bearing 5-ASA and Camylofine dihydrochloride for the treatment of ulcerative colitis.
    Dubey R; Dubey R; Omrey P; Vyas SP; Jain SK
    J Drug Target; 2010 Sep; 18(8):589-601. PubMed ID: 20088681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eudragit S100 coated iron oxide-chitosan nanocomposites for colon targeting of 5-aminosalicylic acid ameliorate ulcerative colitis by improving intestinal barrier function and inhibiting NLRP3 inflammasome.
    Zhang D; Wan H; Zhao R; Zhang Y; Chen H
    Int Immunopharmacol; 2024 Sep; 139():112661. PubMed ID: 39008936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.